NEFL and multiple system atrophy: As NfL is increased in many neurodegenerative diseases, including several multisystemic ataxias19 and atypical parkinsonian conditions,9 the biomarker value of NfL levels lie in their ability to reflect disease severity and progression and in their potential as stratification biomarkers for MSA drug trials.